fda compounding glp 1 Warns on Certain Forms of Compounded Semaglutide FDA and Novo Nordisk Warned
Description
These updates are not the same as full peer-reviewed publications, so treat them as preliminary until complete data are published

Compounding is meant to be used only in narrow circumstances, such as during an official drug shortage or when a patient cannot take a branded medication for specific medical reasons

[DOI] [PubMed] [Google Scholar] 36

Repeated stress activation is not merely life stress. Over time, it can alter HPA-axis signaling and contribute to insulin resistance, visceral adiposity, immune dysregulation, chronic inflammation, and mood disorders

Top row: fundus photos from initial presentation
Build and support multidisciplinary teams of frontline clinicians, community partners, physiologists, and behavioral and pharmaceutical scientists to address the knowledge gap in GLP-1RA effects in children and adolescents (see Fig